Trial Profile
Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2019
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms KOPIDO STENT
- 01 Jan 2013 Primary endpoint 'Platelet-function' has been met.
- 30 Apr 2012 New trial record